Literature DB >> 18200676

Natural killer T cells and non-alcoholic fatty liver disease: fat chews on the immune system.

Michael Kremer1, Ian N Hines.   

Abstract

Natural killer T cells (NKT) are an important subset of T lymphocytes. They are unique in their ability to produce both T helper 1 and T helper 2 associated cytokines, thus being capable of steering the immune system into either inflammation or tolerance. Disruption of NKT cell numbers or function results in severe deficits in immune surveillance against pathogens and tumor cells. Growing experimental evidence suggests that hepatosteatosis may reduce resident hepatic as well as peripheral NKT cells. Those models of hepatosteatosis and the change in NKT cell numbers are associated with a disruption of cytokine homeostasis, resulting in a more pronounced release of proinflammatory cytokines which renders the steatotic liver highly susceptible to secondary insults. In this letter to the editor, we focus on recently published data in the World Journal of Gastroenterology by Xu and colleagues demonstrating reduced peripheral NKT cells in patients with non-alcoholic fatty liver disease, compare those findings with ours and others in different animal models of hepatosteatosis, and hypothesize about the potential underlying mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18200676      PMCID: PMC2679142          DOI: 10.3748/wjg.14.487

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

1.  Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage.

Authors:  M Guebre-Xabier; S Yang; H Z Lin; R Schwenk; U Krzych; A M Diehl
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

Review 2.  Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance.

Authors:  Herbert Tilg; Gökhan S Hotamisligil
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

3.  Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease.

Authors:  Cheng-Fu Xu; Chao-Hui Yu; You-Ming Li; Lei Xu; Juan Du; Zhe Shen
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

4.  Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis.

Authors:  G Eberl; H R MacDonald
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

5.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Authors:  J Cui; T Shin; T Kawano; H Sato; E Kondo; I Toura; Y Kaneko; H Koseki; M Kanno; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

6.  Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.

Authors:  Zhiping Li; Mark J Soloski; Anna Mae Diehl
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

7.  Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.

Authors:  S Sharif; G A Arreaza; P Zucker; Q S Mi; J Sondhi; O V Naidenko; M Kronenberg; Y Koezuka; T L Delovitch; J M Gombert; M Leite-De-Moraes; C Gouarin; R Zhu; A Hameg; T Nakayama; M Taniguchi; F Lepault; A Lehuen; J F Bach; A Herbelin
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

8.  Innate immunity in the liver.

Authors:  Zhiping Li; Anna Mae Diehl
Journal:  Curr Opin Gastroenterol       Date:  2003-11       Impact factor: 3.287

Review 9.  Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature.

Authors:  Anoop Misra; Abhimanyu Garg
Journal:  Medicine (Baltimore)       Date:  2003-03       Impact factor: 1.889

10.  Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis.

Authors:  Zhiping Li; Jude A Oben; Shiqi Yang; Huizhi Lin; Elizabeth A Stafford; Mark J Soloski; Steven A Thomas; Anna Mae Diehl
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

View more
  7 in total

Review 1.  Roles of liver innate immune cells in nonalcoholic fatty liver disease.

Authors:  Yu-Tao Zhan; Wei An
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 2.  CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

Authors:  Sonia M Najjar; Lucia Russo
Journal:  Semin Immunopathol       Date:  2013-11-21       Impact factor: 9.623

Review 3.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Semin Immunopathol       Date:  2009-05-14       Impact factor: 9.623

4.  Serum soluble major histocompatibility complex class I-related chain A/B expression in patients with alcoholic liver disease in Hainan Li community.

Authors:  Xiaobin Wei; Biqiong Ren; Danqin Lin; Bin Luo; Xianxian Fu; Chunyun Li; Huan Xia; Xi Xiao; Ping Yu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 5.  Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease.

Authors:  Sha Li; Hor-Yue Tan; Ning Wang; Yigang Feng; Xuanbin Wang; Yibin Feng
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

Review 6.  Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.

Authors:  Howard C Masuoka; Naga Chalasani
Journal:  Ann N Y Acad Sci       Date:  2013-01-30       Impact factor: 5.691

Review 7.  Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System.

Authors:  Pietro Torre; Benedetta Maria Motta; Roberta Sciorio; Mario Masarone; Marcello Persico
Journal:  Front Med (Lausanne)       Date:  2021-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.